Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients

AIM: To compare the outcomes of GDPT [gemcitabine (G), cisplatin (D), prednisone (P), thalidomide (T)] versus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) in treating newly diagnosed PTCL (peripheral T-cell lymphoma). METHODS: An open-label prospective clinical trial with 153 newly...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Med Oncol
Glavni autori: Sun, Yuanyuan, Li, Ling, Li, Xin, Zhang, Lei, Wang, Xinhua, Fu, Xiaorui, Sun, Zhenchang, Zhang, Xudong, Li, Zhaoming, Wu, Jingjing, Yu, Hui, Chang, Yu, Yan, Jiaqin, Wu, Xiaolong, Zhou, Zhiyuan, Nan, Feifei, Tian, Li, Zhang, Mingzhi
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278096/
https://ncbi.nlm.nih.gov/pubmed/32550864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920923829
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items